In both model cell lines and cells from patients with HGPS, valproic acid and TSA lowered progerin levels, which allowed for rescue of heterochromatin organization and reorganization of transcripts (Columbaro et al, 2005; Stephens et al, 2017). The gene discussed is LMNA; the disease is Hutchinson-Gilford progeria syndrome.